GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (XTER:EUZ) » Definitions » Gross-Profit-to-Asset %

Eckert & Ziegler SE (XTER:EUZ) Gross-Profit-to-Asset % : 31.16% (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Eckert & Ziegler SE Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Eckert & Ziegler SE's annualized Gross Profit for the quarter that ended in Mar. 2024 was €139.6 Mil. Eckert & Ziegler SE's average Total Assets over the quarter that ended in Mar. 2024 was €447.9 Mil. Therefore, Eckert & Ziegler SE's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 31.16%.


Eckert & Ziegler SE Gross-Profit-to-Asset % Historical Data

The historical data trend for Eckert & Ziegler SE's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eckert & Ziegler SE Gross-Profit-to-Asset % Chart

Eckert & Ziegler SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.66 30.76 28.59 28.27 27.48

Eckert & Ziegler SE Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.53 28.07 29.64 24.03 31.16

Competitive Comparison of Eckert & Ziegler SE's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Eckert & Ziegler SE's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eckert & Ziegler SE's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Eckert & Ziegler SE's Gross-Profit-to-Asset % falls into.



Eckert & Ziegler SE Gross-Profit-to-Asset % Calculation

Eckert & Ziegler SE's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=116.343/( (407.456+439.364)/ 2 )
=116.343/423.41
=27.48 %

Eckert & Ziegler SE's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=139.58/( (439.364+456.522)/ 2 )
=139.58/447.943
=31.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Eckert & Ziegler SE Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Eckert & Ziegler SE (XTER:EUZ) Business Description

Traded in Other Exchanges
Address
Robert-Rossle-Street 10, Berlin, BB, DEU, D-13125
Eckert & Ziegler Strahlen- und Medizintechnik AG is a provider of isotope technology for medical, scientific and industrial use. It is primarily engaged in the business activities of cancer therapy, industrial radiometry, and nuclear-medical imaging. The business segments of the group are Isotope products; Medical and Holding company. The company generates maximum revenue from Isotope products segment. Geographically, it derives a majority of revenue from Europe and also has a presence in North America, Asia-Pacific, and other regions.
Executives
Dr. Andreas Eckert Supervisory Board
Frank Perschmann Supervisory Board
Dr. Hakim Bouterfa Board of Directors
Prof. Dr. Wolfgang Maennig Supervisory Board
Dr. Harald Hasselmann Board of Directors

Eckert & Ziegler SE (XTER:EUZ) Headlines

No Headlines